Bio-Path Holdings Inc Stock Nasdaq
Equities
US09057N2018
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.32M |
---|---|---|---|---|---|
Net income 2024 * | -12M | Net income 2025 * | -13M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.15
x | P/E ratio 2025 * |
-0.15
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.89% |
Latest transcript on Bio-Path Holdings Inc
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 07-05-09 | |
Peter Nielsen
CEO | Chief Executive Officer | 75 | 07-05-09 |
Douglas Morris
FOU | Founder | 68 | 07-05-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Morris
FOU | Founder | 68 | 07-05-09 |
Heath Cleaver
BRD | Director/Board Member | 51 | 14-02-10 |
Peter Nielsen
CEO | Chief Executive Officer | 75 | 07-05-09 |
1st Jan change | Capi. | |
---|---|---|
+19.56% | 42.68B | |
-2.01% | 42.4B | |
+45.21% | 40.04B | |
-6.20% | 28.31B | |
+6.67% | 24.94B | |
-21.41% | 18.96B | |
+30.61% | 12.3B | |
-2.64% | 11.95B | |
-3.36% | 11.55B |